首页> 外文期刊>BMC Complementary and Alternative Medicine >Herbal formula GAPT prevents beta amyloid deposition induced Ca 2+ /Calmodulin-dependent protein kinase II and Ca 2+ /Calmodulin-dependent protein phosphatase 2B imbalance in APPV717I mice
【24h】

Herbal formula GAPT prevents beta amyloid deposition induced Ca 2+ /Calmodulin-dependent protein kinase II and Ca 2+ /Calmodulin-dependent protein phosphatase 2B imbalance in APPV717I mice

机译:草药配方GAPT可防止APPV717I小鼠中β淀粉样蛋白沉积诱导的Ca 2+ /钙调蛋白依赖性蛋白激酶II和Ca 2+ /钙调蛋白依赖性蛋白磷酸酶2B失衡

获取原文
           

摘要

Background Synaptic dysfunction is one of the pathological characteristics of Alzheimer's disease (AD), which is directly related to the progressive decline of cognitive function. CaMKII and CaN have been found to play important roles in memory processes and synaptic transmission. So present study aimed to elucidate relationships between CaMKII, CaN and cognitive decline in APPV717I mice, and to reveal whether the cognitive improving effects of GAPT is conducted through rebalance CaMKII and CaN. Methods Three-month-old-male APPV717I mice were randomly divided into ten groups ( n =?12 per group) and received intragastrically administrated vehicle, donepezil or different doses of herbal formula GAPT for 8 or 4?months. Three-month-old male C57BL/6?J mice was set as vehicle control. Results Immunohistochemistry analysis showed that there were CaMKII expression decrease in the CA1 region of APPV717I transgenic mice, while the CaMKII expression of donepezil or GAPT treated transgenic mice were all increased. And there were CaN expression increase in the brain cortex of APPV717I transgenic mice, while there were decrease of CaN expression in donepezil or GAPT treated transgenic group. Western blot analysis showed the similar expression pattern without significant difference. Conclusion GAPT extract have showed effectiveness in activating the expression of CaMKII and inhibiting the expression of CaN either before or after the formation of amyloid plaques in the brain of APPV717I transgenic mice, which may in certain way alleviated neuron synaptic dysfunction in AD.
机译:背景突触功能障碍是阿尔茨海默氏病(AD)的病理特征之一,直接与认知功能的逐步下降有关。已经发现CaMKII和CaN在记忆过程和突触传递中起重要作用。因此,本研究旨在阐明CaMKII,CaN与APPV717I小鼠认知能力下降之间的关系,并揭示GAPT的认知改善作用是否通过重新平衡CaMKII和CaN来进行。方法将3个月大的雄性APPV717I小鼠随机分为10组(每组n = 12),并分别接受胃内给药媒介物,多奈哌齐或不同剂量的草药GAPT,持续8或4个月。将3个月大的雄性C57BL /6ΔJ小鼠作为媒介物对照。结果免疫组织化学分析表明,APPV717I转基因小鼠CA1区CaMKII表达降低,而多奈哌齐或GAPT处理的转基因小鼠CaMKII表达均升高。在APPV717I转基因小鼠的大脑皮层中,CaN表达增加,而在多奈哌齐或GAPT处理的转基因组中,CaN表达减少。 Western印迹分析显示相似的表达模式,没有显着差异。结论GAPT提取物在APPV717I转基因小鼠脑内淀粉样斑块形成之前或之后均能激活CaMKII的表达并抑制CaN的表达,从而在一定程度上减轻了AD的神经元突触功能障碍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号